The nation of Zimbabwe has turned down a major American healthcare agreement worth $367m (272 million pounds) over five years due to the United States' request for confidential biological samples.
This move became public after a government memo dated December was disclosed, which showed President Emmerson Mnangagwa deemed the deal was "skewed".
An official representative later clarified that the United States was requesting biological samples for scientific study and commercial purposes but was unwilling to share the benefits from future medical innovations.
"We are forced to start the difficult and regrettable process of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided over $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for further negotiations to secure a deal acceptable to both sides so the country's vital HIV programme can continue.
Wider Context
This development follows a similar case in neighbouring Kenya, where a high court blocked a similar health funding agreement following concerns were raised about the security of citizens' medical information.
Since returning to office last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump argued its spending was "wasteful" and his administration was pursuing direct bilateral agreements to enhance openness and responsibility.
According to statements, Sixteen nations in Africa have so far signed similar agreements, constituting over $18.3bn of fresh investment.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment through US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to share its biological resources and data indefinitely, with no equivalent guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that could result from that provided information," he stated.
"Effectively, our country would supply the raw materials for scientific discovery without any certainty that the resulting innovations would be available to our people should a new disease outbreak arise."
National Interest and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining frameworks already established through the international organization.
Mangwana cited its Pandemic Benefit-Sharing framework designed to deal with potential pandemics.
"This mechanism is intended to ensure that when a country provides its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," he added.
"We encourage ongoing discussions with our American counterparts on how future collaboration could be arranged in a way that respects the sovereignty and interests of each country."
Health Experts Response
Medical experts said it understood the official position, but recommended that negotiations need to persist considering much of the nation's HIV programmes depended on international support.
"Where specific concerns exist, including those relating to data governance or agreement terms, these can frequently be addressed via technical clarification and negotiated safeguards," the group commented.
The situation highlights the continuing debate between receiving vital foreign assistance and protecting local interests in an increasingly interconnected world.